Related Experiment Video
Updated: Mar 18, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Hepatitis Aand E Co-Infection with Worst Outcome
Anjum Saeed1, Huma Arshad Cheema2, Asaad Assiri1
11. Department of Pediatric, Collge of Medicine, King Saud University Medical City, Riyadh, Saudi Arabia. 2. Prince Abdullah Bin Khalid Celiac Disease Research Chair, King Saud University Medical City, Riyadh, Saudi Arabia.
Concurrent infections with hepatitis A and E are rare in children. This case highlights a severe outcome, emphasizing the need for physician awareness in managing co-infections, especially in regions with poor sanitation.
Area of Science:
- Hepatology
- Pediatric Infectious Diseases
- Public Health
Background:
- Hepatitis A and E are common in developing countries like Pakistan due to poor sanitation and economic factors.
- While typically self-limiting in children, co-infections with multiple hepatitis viruses are rare but can lead to severe outcomes.
- Physicians must be vigilant for co-infections presenting with atypical symptoms or unusual disease progression.
Observation:
- A pediatric case presented with concurrent acute hepatitis A and E infections.
- The patient exhibited symptoms suggestive of hepatic encephalopathy.
- Despite supportive care, the clinical course was severe.
Findings:
- The co-infection of hepatitis A and E in a child led to a poor prognosis.
- Hepatic encephalopathy was a critical complication in this case.
- This case underscores the potential for severe outcomes in viral hepatitis co-infections.
Implications:
- Highlights the importance of considering co-infections in pediatric hepatitis, particularly in endemic areas.
- Emphasizes the need for heightened clinical suspicion and prompt management strategies for severe hepatitis cases.
- Informs public health strategies for preventing viral hepatitis transmission through improved sanitation and hygiene.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Related Concept Videos
Hepatitis
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acute Pancreatitis II: Clinical Manifestations and Management
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment